Ultralife (NASDAQ:ULBI) Share Price Crosses Above 200-Day Moving Average of $9.05

Ultralife Co. (NASDAQ:ULBIGet Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $9.05 and traded as high as $10.19. Ultralife shares last traded at $10.00, with a volume of 64,220 shares.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ULBI shares. StockNews.com lowered Ultralife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, May 2nd. Benchmark raised their target price on shares of Ultralife from $12.00 to $13.00 and gave the stock a “buy” rating in a research note on Tuesday, March 5th.

Get Our Latest Analysis on ULBI

Ultralife Price Performance

The company has a debt-to-equity ratio of 0.18, a quick ratio of 2.16 and a current ratio of 4.03. The company has a market cap of $166.20 million, a P/E ratio of 15.63 and a beta of 0.99. The firm’s fifty day moving average is $10.97 and its two-hundred day moving average is $9.05.

Ultralife (NASDAQ:ULBIGet Free Report) last announced its quarterly earnings data on Thursday, April 25th. The technology company reported $0.21 EPS for the quarter. Ultralife had a return on equity of 10.31% and a net margin of 6.19%. The business had revenue of $41.93 million for the quarter.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Ultralife during the third quarter valued at approximately $36,000. Citigroup Inc. bought a new stake in Ultralife in the 3rd quarter valued at $74,000. Victory Capital Management Inc. purchased a new stake in Ultralife in the 4th quarter worth $59,000. Algert Global LLC bought a new position in shares of Ultralife during the 3rd quarter valued at about $106,000. Finally, O Shaughnessy Asset Management LLC purchased a new position in shares of Ultralife during the first quarter valued at about $100,000. 30.68% of the stock is currently owned by institutional investors.

Ultralife Company Profile

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Recommended Stories

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.